SCHEMBL26445289

SCHEMBL26445289

c1cnc2c(c1)c1cccc3oc4cccc2c4c31

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.42
NPC1 O15118 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPT P10636 4/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
GAA P10253 1/20 0.39
LMNA P02545 2/20 0.37
PARP1 P09874 3/20 0.37
TSHR P16473 3/20 0.37
MMP2 P08253 2/20 0.37
GMNN O75496 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
MMP9 P14780 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19062048 0.88 L3MBTL1 (0.42) HSP90AA1NPC1L3MBTL1MEN1KMT2A
SCHEMBL26445231 0.80 L3MBTL1 (0.34) HSP90AA1NPC1L3MBTL1MEN1KMT2A
SCHEMBL23630880 0.79 KMT2A (0.42) NPC1L3MBTL1MEN1KMT2AKDM4E
SCHEMBL26445250 0.78 CCR1 (0.37) HSP90AA1NPC1L3MBTL1MEN1KMT2A
SCHEMBL20067225 0.78 MAOA (0.50) NPC1L3MBTL1MEN1KMT2AKDM4E
SCHEMBL24791088 0.77 ALOX5 (0.42) NPC1MEN1KMT2AKDM4EALDH1A1
SCHEMBL25495306 0.75 NCOA1 (0.36) HSP90AA1NPC1L3MBTL1MEN1KMT2A
SCHEMBL6925972 0.75 KDM4E (0.48) HSP90AA1NPC1L3MBTL1MEN1KMT2A
SCHEMBL29625837 0.75 KMT2A (0.58) HSP90AA1NPC1L3MBTL1MEN1KMT2A
SCHEMBL148991 0.75 KMT2A (0.58) HSP90AA1NPC1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230135868-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC EQUIPMENT, LIGHTING APPARATUS, MOVING BODY, AND EXPOSURE LIGHT SOURCE CANON KABUSHIKI KAISHA (JP) 2023-05-04 US disclosed
US-20230135868-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC EQUIPMENT, LIGHTING APPARATUS, MOVING BODY, AND EXPOSURE LIGHT SOURCE CANON KABUSHIKI KAISHA (JP) 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230135868-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC EQUIPMENT, LIGHTING APPARATUS, MOVING BODY, AND EXPOSURE LIGHT SOURCE L1CAM, APOL1, TBL2 HSP90AA1 4323/4885NPC1 3691/4885L3MBTL1 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.